By Erika P. Hamilton et al.
Source primeinc
Intended Audience: Oncologists, NPs/PAs, nurses, and pharmacists who care for patients with breast cancer in academic, community, rural and system-based practices
Novel and emerging therapies are transforming the treatment of HR+/HER2- breast cancer. Ensure you and your team are up to date on the latest clinical evidence supporting use of these therapies. In this on-demand video activity, experts will review real-world data from community oncology clinics participating in a quality improvement initiative designed to improve care for patients with breast cancer.